Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, April 13, 2022
Biofrontera Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Biofrontera Pharma’s cGMP laboratory in Leverkusen, Germany, as a contract laboratory for batch control and stability testing of Ameluz® (aminolevulinic acid ...
read more
Wednesday, April 06, 2022
Asymchem Laboratories (Tianjin) Co., Ltd. announced the company has completed construction of a new building at its Dunhua, China, production site. The expansion will add nearly 500m³ of batch capacity to meet demands for upcoming commercialization ...
read more
The Flamma Group, a company producing and commercializing small molecule Active Pharmaceutical Ingredients (APIs) for the life science industry as well as a Contract Development and Manufacturing Organization (CDMO) of New Chemical Entities (NCEs) ...
read more
Lonza announced the completion of a laboratory expansion at its active pharmaceutical ingredients (API) manufacturing site at Nansha, China. The expansion focused on extending the capabilities and capacity of development laboratories and kilogram-...
read more
Orbit Discovery has announced the commencement of a partnership with WuXi AppTec, a global provider of R&D and manufacturing services that enable the global pharmaceutical and healthcare industry.
read more
Wednesday, March 02, 2022
Sterling Pharma Solutions has reached an agreement with Novartis to acquire its Ringaskiddy campus (Novartis Ringaskiddy Limited), near Cork, Ireland. Financial details of the sale, which is expected to close in Q4, 2022, have not been disclosed.
read more
After one year of re-construction, the new facilities in close proximity to Coriolis’ headquarters in Martinsried will significantly increase Coriolis’ capabilites for ATMP development. Formulation development for ATMPs, including cell culture ...
read more
Monday, December 13, 2021
Ascensus Specialties announced its acquisition of Wychem Limited, a UK-based manufacturer of fine chemicals for pharmaceutical and specialty applications. This transaction complements Ascensus’ existing capabilities and reinforces the Company’s focus...
read more
Thursday, December 09, 2021
Novasep, a supplier of services and technologies for the life sciences industry, has announced a €6 million investment on its Chasse-sur-Rhône site, France (38). This investment will increase and modernize its manufacturing capabilities to support ...
read more
Monday, November 29, 2021
Provepharm Life Solutions, a French private pharmaceutical company that finds new applications for well-known molecules, today announces that it has been granted FDA (Food and Drug Administration) authorization to produce its own Active ...
read more
Heraeus Pharmaceutical Ingredients’ additional production line for Platinum-based highly potent active pharmaceutical ingredients (Pt hAPIs) is now fully operational at the company’s headquarters in Hanau, Germany. Heraeus, a business line of Heraeus...
read more
MediPharm Labs Corp., a pharmaceutical company specialized in research-driven development and manufacturing of cannabis API and finished products, has received a Drug Establishment Licence (the “DEL”) issued by Health Canada in accordance with the ...
read more
Novasep, a supplier of services and technologies for the life sciences industry, announced a €6.1 million investment at its Mourenx facility(Pyrénées-Atlantiques – France). This investment will modernize its API manufacturing facility.
read more
Danaher Corporation announced that Danaher has entered into a definitive agreement to acquire privately-held Aldevron, for a cash purchase price of approximately $9.6 billion. Danaher expects to finance the acquisition using cash on hand and/or ...
read more
Vectura Group plc announced it has signed an agreement with Incannex Healthcare Limited, an Australian cannabinoid medicines development company, to provide pre-clinical development services for IHL-216A, Incannex’s proprietary inhaled drug product ...
read more